Insider · CIK 0001413824

ARMER THOMAS A

Reports to the SEC for 1 company · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001413824

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-01-25	MAP Pharmaceuticals, Inc.F Tax Payment	Director, Chief Scientific Officer	FTax Payment	−1,034 sh	$24.75	−$25.6K	130,878
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−8,250 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−40.8K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−22.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−50K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−75K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−50K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−27.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−32.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−4,500 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.U Disposition from Tender	Director, Chief Scientific Officer	UDisposition from Tender	−223K sh	$25.00	−$5.57M	0
2013-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+2,250 sh	—	—	133,128
2013-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−2,250 sh	—	—	4,500
2013-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	Director, Chief Scientific Officer	FTax Payment	−846 sh	$24.75	−$20.9K	132,282
2013-01-25	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+2,750 sh	—	—	131,912
2013-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−2,750 sh	—	—	8,250
2013-01-23	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+39.6K sh	$6.39	+$253K	188,782
2013-01-23	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−59.6K sh	$24.76	−$1.48M	129,162
2013-01-23	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−39.6K sh	—	—	0
2012-02-14	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−31K sh	$15.62	−$484K	149,162
2012-02-13	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−2,800 sh	$16.00	−$44.8K	180,161
2012-02-08	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−26.2K sh	$16.00	−$419K	182,961
2012-02-06	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−19.9K sh	$15.00	−$298K	209,162
2012-02-03	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−132 sh	$15.00	−$1,980	229,030
2012-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+2,250 sh	—	—	230,105
2012-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−2,250 sh	—	—	6,750
2012-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	Director, Chief Scientific Officer	FTax Payment	−943 sh	$13.84	−$13.1K	229,162
2012-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	Director, Chief Scientific Officer	AAward	+11K sh	—	—	11,000
2012-01-25	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+32.5K sh	—	—	32,500
2011-12-19	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−20K sh	$14.00	−$280K	227,855
2011-03-17	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+35.8K sh	$0.74	+$26.6K	247,855
2011-03-17	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−35.8K sh	—	—	0
2011-03-04	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−30K sh	$16.10	−$483K	212,009
2011-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	Director, Chief Scientific Officer	AAward	+9,000 sh	—	—	9,000
2011-01-26	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+27.5K sh	—	—	27,500
2010-02-02	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2009-12-14	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	40,847
2009-12-14	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.36	+$33.6K	342,403
2009-12-14	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−10K sh	$9.54	−$95.4K	332,403
2009-05-27	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−60K sh	—	—	35,846
2009-05-27	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+60K sh	$0.74	+$44.6K	392,403
2009-05-27	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−60K sh	$10.01	−$601K	332,403
2009-05-26	MAP Pharmaceuticals, Inc.S Sale	Director, Chief Scientific Officer	SSale	−40K sh	$9.00	−$360K	332,403
2009-05-20	MAP Pharmaceuticals, Inc.J Other	Director, Chief Scientific Officer	JOther	+1,423 sh	$2.63	+$3,749.605	332,403
2009-02-11	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+75K sh	$10.37	+$778K	75,000
2008-01-22	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, Chief Scientific Officer	AAward	+50K sh	$13.12	+$656K	50,000

Recent filings

Accepted (ET)
Mar 44
ARMER THOMAS A0001181431-13-014241
SEC(opens sec.gov)
Jan 294
ARMER THOMAS A0001181431-13-005438
SEC(opens sec.gov)
Jan 254
ARMER THOMAS A0001181431-13-004934
SEC(opens sec.gov)
Feb 144
ARMER THOMAS A0001181431-12-008825
SEC(opens sec.gov)

Companies

MAP Pharmaceuticals, Inc.Director, Chief Scientific Officer

Address

C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200

MOUNTAIN VIEW, CA, 94043